Suppr超能文献

结核病能让我们了解如何对抗多重耐药革兰氏阴性杆菌。

What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli.

作者信息

Banerjee Ritu, Starke Jeffrey R

机构信息

Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States.

Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.

出版信息

J Clin Tuberc Other Mycobact Dis. 2016 Apr 1;3:28-34. doi: 10.1016/j.jctube.2016.03.004. eCollection 2016 May.

Abstract

There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategies that have been used by the global TB community to address the MDR TB problem, including approaches to: encourage appropriate use of anti-TB medications, enhance appropriate utilization of molecular diagnostic testing, facilitate development of new antimicrobial agents, and strengthen surveillance systems and infection control practices. Understanding the successes and challenges of these strategies for MDR TB control will be instructive for efforts to curb emergence and spread of MDR GNB.

摘要

耐多药结核病(MDR TB)和耐多药革兰氏阴性杆菌(MDR GNB)这两种大流行疾病之间存在显著相似之处,尽管这些病原体在发病机制和流行病学方面存在根本差异。从这个角度来看,我们强调了全球结核病界为解决耐多药结核病问题所采用的几种策略,包括以下方法:鼓励合理使用抗结核药物、加强分子诊断检测的合理利用、促进新型抗菌药物的研发,以及加强监测系统和感染控制措施。了解这些耐多药结核病控制策略的成功经验和挑战,将为遏制耐多药革兰氏阴性杆菌的出现和传播提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/6850263/f4fa8dd8fe9b/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验